11 results
10-K
2021 FY
LIANY
LianBio
31 Mar 22
Annual report
8:55am
for human capital, particularly as we seek to attract and retain talent with solid experience in the biotechnology and pharmaceutical sectors. Our human
424B4
LIANY
LianBio
2 Nov 21
Prospectus supplement with pricing info
4:02pm
consistently focused on identifying and cultivating top-tier talent.
We are led by Yizhe Wang, Ph.D., our Chief Executive Officer, who has significant
S-1/A
uyu3c3j
8 Oct 21
IPO registration (amended)
5:09pm
S-1
9db6hhff2ifmnpg5ye8
1 Oct 21
IPO registration
4:52pm
DRS/A
ogwnhg8
21 Sep 21
Draft registration statement (amended)
12:00am
DRS/A
3pbs6xhll kz
2 Sep 21
Draft registration statement (amended)
12:00am
DRS/A
zdou5tx92 c37izj
9 Aug 21
Draft registration statement (amended)
12:00am
DRS
ujyye
28 Jun 21
Draft registration statement
12:00am
- Prev
- 1
- Next